Press Releases
U.S. Rozanolixizumab (Rystiggo) Market Outlook 2025–2035: Key Developments and Future Scope
The global Rozanolixizumab (Rystiggo) market is poised for significant expansion from 2025 to 2035, driven by rising diagnosis of autoimmune neuromuscular disorders, increasing adoption of
FMI
December 5, 2025